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Instead of Invasive Coronary AngiographySex Effects in Patients With Suspected CADAround 50% of women die of cardiovascular diseases.
Diagnostic accuracy in detecting significant coronary
artery disease (CAD) differs between men and
women, underlining the need for further investiga-
tion of sex-specific differences (1). In this subanalysis
of the prospective CAD-Man (Coronary Artery Disease
Management) trial, we evaluated if women, compared
with men, benefit from undergoing computed to-
mography angiography (CT) instead of invasive cor-
onary angiography (ICA) in terms of procedural
complications. Events in the follow- up period were
defined in the study protocol (2). The CAD-Man trial
showed that CT is a safe and accurate gatekeeper toICA. Initial CT instead of ICA reduced minor compli-
cations and the length of hospitalization, while
increasing the diagnostic yield of ICA.
Patients with suspected CAD based on atypical
chest pain and a clinical indication for ICA were
randomly assigned to CT or ICA (2). Major procedural
complications (death, stroke, myocardial infarction,
and other complications prolonging hospitalization
by at least 24 h) and minor procedural complications
(e.g., groin hematoma, groin pain, infection, allergy,
thrombosis, and arteriovenous fistula), defined as
occurring within 48 h of the last related procedure,
were compared between men and women.
The sex analysis was a planned secondary analysis
(2). The chi-square test was used to evaluate minor
and major procedural complications. Additionally, a
post hoc power calculation was performed. The cal-
culations were performed by nQuery release 7 (Sta-
tistical Solutions Ltd., Boston, Massachusetts).
Assuming the observed overall complication rate of
7.3% and the sample size of the study, differences in
complication rates of 8% (i.e., 3.3% vs. 11.3%) or larger
could have been detected (power 80%, type I
error ¼ 0.05; 2-sided).
Procedural complications occurred less often in
women in the CT group compared with the ICA group
(CT: 1.1% vs. ICA: 11.5%). Procedural complications
were similar in men in both groups (CT: 7.6% vs. ICA:
9.5%). Major procedural complications were uncom-
mon in the CT and ICA group in both sexes (Table 1).
Minor procedural complications occurred less often in
women in the CT group compared with the ICA group
(Table 1). The interaction sex study arm regarding
procedural complication was p ¼ 0.072.
The number of any events at long-term follow-up
at 3.3 years was similar in women and men in both
groups (Table 1).
This study is limited by its single-center design and
the small total number of adverse events. Although
earlier studies revealed differences between women
and men regarding the prevalence and symptoms of
CAD, ours is the first study analyzing sex differences
in terms of outcomes of diagnostic procedures (CT
and ICA). This study shows that women with atypical
chest pain and a clinical indication for coronary
evaluation may benefit from a strategy based on CT
instead of ICA, specifically due to a reduction in mi-
nor procedural complications.
Possible reasons for these results are:
1. Having a lower pretest probability of disease than
men and a lower rate of complex diseases women
are expected to benefit less from initial ICA.
2. Women with obstructive CAD have more comor-
bidities, present with atypical symptoms, and tend
TABLE 1 Any Procedural Complications and Events at Long-Term Follow-Up at 3.3 Years
Women (n ¼ 166) Men (n ¼ 163)
CT (n ¼ 88) ICA (n ¼ 78) p Value Power CT (n ¼ 79) ICA (n ¼ 84) p Value Power
Procedural complications 1 (1.1) 9 (11.5) 0.005* 79.6 6 (7.6) 8 (10.5) 0.66 15.7
Major procedural complications 0 0 1 (1.3) 0 0.298 19.1
Myocardial infarction 0 0 1 (1.3) 0 0.298 19.1
Death 0 0 0 0
Minor procedural complications 1 (1.1) 9 (11.5) 0.005* 79.6 5 (6.3) 8 (10.5) 0.450 15.7
Hematoma at puncture site 0 8 (10.3) 0.002 86.0 1 (1.3) 7 (8.2) 0.038 53.2
Bradycardia 1 (1.1) 0 0.345 13.9 1 (1.3) 0 0.298 19.1
Angina without infarction 0 0 1 (1.3) 0 0.298 19.1
Allergoid reaction to contrast agent 0 0 1 (1.3) 0 0.298 19.1
Stent migration 0 0 0 1 (1.2) 0.334 15.0
Hypotension requiring treatment 0 1 (1.3) 0.287 20.0
Number of any event at long-term follow-up at 3.3 years 2 (2.3) 2 (2.5) 1 5 (6.3) 5 (5.9) 0.905 5.7
Myocardial infarction 0 0 1 (1.3) 0 0.298 19.1
Cardiac death 0 1 (1.3) 0.287 20.0 0 0
Stroke 0 1 (1.3) 0.287 20.0 0 0
Unstable angina pectoris 0 0 1 (1.3) 0 0.298 19.1
Re-revascularization or first revascularization 2 (2.3) 1 (1.3) 0.632 7.3 4 (5.1) 4 (5.9) 1
Values are n (%). *Significant after Bonferroni correction with factor 2 for testing of 2 subgroups.
CT ¼ computed tomography; ICA ¼ invasive coronary angiography.
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889to develop plaque erosion (3). Thus, they are ex-
pected to have higher risks for procedural compli-
cations during ICA with poorer outcome (4).
3. Women more often have microvascular disease
rather than obstructive luminal stenosis of the
large epicardial vessels (5), and thus, benefit more
from risk factor modification than from coronary
revascularization. In addition, CT allows more
detailed risk stratification, which may improve
outcomes, especially in women.Maria Bosserdt, PhDy
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